References
- Bacci G, Gherlinzoni F, Picci P, Van Horn J R, Jaffe N, Guerra A, Ruggieri P, Biagini R, Capanna R, Toni A, et al. Adriamycin methotrexate high dose versus adriamycin methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of theextremities: a randomized study. Eur J Cancer Clin Oncol 1986; 22(11)1337–45
- Barlogie B, Raber M N, Schumann J, Johnson T S, Drewinko B, Swartzendruber D E, Gohde W, Andreeff M, Freireich E J. Flow cytometry in clinical cancer research. Cancer Res 1983; 43(9)3982–97
- Bauer H C, Kreicbergs A, Tribukait B. DNA microspectro-photometry of bone sarcomas in tissue sections as compared to imprint and flow DNA analysis. Cytometry 1986; 7(6)544–50
- Bauer H C, Kreicbergs A, Silfversward C, Tribukait B. DNA analysis in the differential diagnosis of osteosarcoma. Cancer 1988; 61(7)1430–6
- Bauer H C, Kreicbergs A. Feulgen DNA stainability of bone tumors after demineralization. Cytometry 1987; 8(6)590–4
- Broders A C, Hargrave R, Meyerding H W. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet 1939; 69: 267–80
- Cox D R. Regression models and life tables. J R Stat Soc, ser B 1972; 34: 187–220
- Dahlin D C, Coventry M B. Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg (Am) 1967; 49(1)101–10
- Dahlin D C. Pathology of osteosarcoma. Clin Orthop 1975, 111: 23–32
- Edmonson J H, Green S J, Ivins J C, Gilchrist G S, Creagan E T, Pritchard D J, Smithson W A, Dahlin D C, Taylor W F. Acontrolled pilot study of high dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 1984; 2(3)152–6
- Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 1987; 5(1)21–6
- Enneking W F. A system of staging musculoskeletal neoplasms. Clin Orthop 1986, 204: 9–24
- Hiddemann W, Roessner A, Wormann B, Mellin W, Klockenkemper B, Bosing T, Buchner T, Grundmann E. Tumor heterogeneity in osteosarcoma as identified by flow cytometry. Cancer 1987; 59(2)324–8
- Kreicbergs A, Zetterberg A. Cytophotometric DNA measurements of chondrosarcoma: metnodologic aspects of measurements in tissue sections from old paraffin embedded specimens. Anal Quant Cytol 1980; 2(2)84–92
- Kreicbergs A, Slezak E, Söderberg G. The prognostic significance of different histomorphologic features in chondrosarcoma. Virchows Arch (Pathol Anat) 1981; 390(1)1–10
- Kreicbergs A, Boquist L, Borssen B, Larsson S E. Prognostic factors in chondrosarcoma: acomparative study of cellular DNA content and clinicopathologic features. Cancer 1982; 50(3)577–83
- Link M P, Goorin A M, Miser A W, Green A A, Pratt C B, Belasco J B, Pritchard J, Malpas J S, Baker A R, Kirkpa-trick J A, et al. The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314(25)1600–6
- Marcove R C, Mike V, Hajek J V, Levin A G, Hutter R V. Osteogenic sarcoma underthe age of twenty one. A review of one hundred and forty-five operative cases. J Bone Joint Surg (Am) 1970; 52(3)411–23
- Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, McPherson K, Peto J, Smith P G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977; 35(1)1–39
- Rosen G, Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: a five year Follow-up (T-10) and preliminary report of new studies (T-12). Prog Clin Biol Res 1985; 201: 39–51
- Rydholm A. Management of patients with soft tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand 1983; 54(Suppl 203)13–77
- Rööser B. Prognosis in soft tissue sarcoma. Acta Orthop Scand 1987; 58(Suppl 225)1–54
- Simon M A, Aschliman M A, Thomas N, Mankin H J. Limb salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg (Am) 1986; 68(9)1331–7
- Strander H, Aparisi T, Broström L Å, . Adjuvant interferon therapy in primary osteosarcoma. Current Concepts of Diagnosis and Treatment of Bone, and Soft Tissue Tumors, H K Uhthoff, et al. Springer Verlag, Berlin 1984; 119–30
- Taylor W F, Ivins J C, Pritchard D J, Dahlin D C, Gilchrist G S, Edmonson J H. Trends and variability in survival among patients with osteosarcoma: a 7-year update. Mayo Clin Proc 1985; 60(2)91–104